Carolinas Wealth Consulting’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Carolinas Wealth Consulting's PFE Position: Q2 2025 in Review
Carolinas Wealth Consulting sold out of Pfizer (PFE) in Q2 2025, closing a stake of 2,506 shares — an estimated $63.5K sold.
Carolinas Wealth Consulting first reported a position in PFE in Q2 2020 and held it in 20 quarters. The position peaked at $238K in Q2 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Carolinas Wealth Consulting reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Carolinas Wealth Consulting sold 2,506 Pfizer shares in Q2 2025, an estimated $63.5K.
- Carolinas Wealth Consulting first reported a position in Pfizer in Q2 2020 and held it in 20 quarters.
- Carolinas Wealth Consulting's Pfizer position peaked at $238K in Q2 2021.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.